To assess the feasibility of smartphone-based digital biomarkers (dBMKs) to objectively measure lower and upper limb motor functions in patients with Duchenne muscular dystrophy (DMD).
No takes yet. Share an insight, caveat, or question.
Tachibana et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: